Business Context and Reporting Period
Company: BIO-RAD LABORATORIES, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: October 27, 2022
Reporting Period: Quarter ended September 30, 2022
This filing serves as a notification that the company has announced its financial results for the third quarter of 2022. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data points. Consequently, the following metrics are not available in this document:
- Revenue
- Profit (Net Income)
- Cash Flow
- Margins
- Debt Levels
- Liquidity Ratios
Note: Specific values for these metrics are not present in the filing text provided; they are referenced only as being included in the attached press release (Exhibit 99.1).
Material Changes
The filing text does not provide specific details regarding material changes in financial performance compared to prior periods. It solely confirms the announcement of the results for the quarter ended September 30, 2022.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 27, 2022) for actual revenue, earnings, and margin figures.
- Verify the specific year-over-year and quarter-over-quarter growth rates mentioned in the press release.
- Check for any updated full-year guidance or outlook provided in the press release.
- Confirm the status of the Class A (BIO) and Class B (BIOb) common stock trading on the New York Stock Exchange.